期刊文献+

子宫内膜癌高危因素的Meta分析 被引量:2

下载PDF
导出
摘要 目的探析子宫内膜癌的高危因素,为临床诊治提供参考.方法:采用文献资料检索法对万方、知网、中国期刊网等文献数据库中有关子宫内膜癌危险因素的文献资料进行检索收集,并对检索文献质量进行评价后,利用可信区间方差分析法对各影响因素的OR和95%CI进行计算分析,以进行子宫内膜癌高危因素分析.结果:Meta分析显示,糖尿病、高血压以及肥胖、初次月经年龄在12岁及以下、恶性肿瘤家族病史等为子宫内膜癌的高位因素,其OR与95%CI值分别为2.51、4.23、2.27、2.39、1.46和2.12-2.94、2.41-7.52、1.47-3.86、1.74-3.26、1.24-1.79.结论:肥胖、高血压、糖尿病以及恶性肿瘤家族病史、初次月经年龄较小、未孕等是导致子宫内膜癌发生的高危因素,临床中应予以关注和重视.
出处 《世界中医药》 CAS 2015年第A02期1389-1390,共2页 World Chinese Medicine
  • 相关文献

参考文献4

二级参考文献38

  • 1Morrow CP, Bundy BN, Homesley HD, et al. Doxorubicin as an adju- vant following surgery and radiation therapy in patients with high - risk endometrial carcinoma, stage I and occult stage II : a Gynecologic On- cology Group Study [J]. Gynecol Oncol, 1990, 36 (2): 166- 171.
  • 2Kuoppala T, Maienpaaa J, Tomas E, et al. Surgically staged high - risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo - radiotherapy [ J ]. Gynecol Oncol, 2008, 110 (2): 190 -195.
  • 3Hogberg T, Rosenberg P, Kristensen G, et al. A randomized phase - Ⅲ study on adjuvant treatment with radiation (RT) ± chemotherapy (CT) in early - stage high - risk endometrial cancer (NSGO - EC - 9501/EORTC55991) [J]. J Clin Oncol, 2007, 25: 5503.
  • 4Hogberg T, Signorelli M, Olivelra CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - - results from two randomised studies [J]. Eur J Cancer, 2010, 46 (13) : 2422 -2431.
  • 5Sutton G, Axelrod JH, Bundy BN, et al. Whole abdominal radiothera- py in the adjuvant treatment of patients with stage Ⅲ and IV endometfial cancer: a gynecologic oncology group study [ J]. Gynecol Oncol, 2005, 97 (3): 755-763.
  • 6Bruzzone M, Migfietta L, Franzone P, et al. Combined treatment with chemotherapy and radiotherapy in high - risk FIGO stage Ⅲ- IV endom- etrial cancer patients [ J ]. Gynecol Oncol, 2004, 93 ( 2 ) : 345 - 352.
  • 7Greven K, Winter K, Underhill K, et al. Final analysis of RTOG - 9708 : adjuvant postoperative irradiation combined with cisplatin/paclita- xel chemotherapy following surgery for patients with high - risk endome- trim cancer [J]. Gynecol Oncol, 2006, 103 (1) : 155 -159.
  • 8Geller MA, Ivy J, Dusenbery KE, et al. A single institution experi- ence using sequential multi - modality adjuvant chemotherapy and radia- tion in the " sandwich" method for high risk endometrial carcinoma [J]. Gynecol Oncol, 2010, 118 (I): 19-23.
  • 9Thigpen T, Blessing JA, Hornessley H, et al. Phase Ⅲ trial of doxo- rubicin with or without cisplain in advanced endometrial caicinoma. A Gynecologic Oncology Group Study [ J ]. J Clin Oneol, 2004, 22 (19) : 3902 - 3908.
  • 10Fleming GF, Brunetto VL, Mundt A J, et al. Randomized trail of doxorubiein (DOX) plus eiaplain (CIS) versus DOX plus CIS plus paclitaxel (TAX) in patient with advanced or requent endometrial caicinoma. A Gynecologic Oncology Group ( GOG ) Study [ J ]. Proc Am Soc Clin Oncol, 2002, 21: 807.

共引文献49

同被引文献26

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部